Healthcare - Biotechnology - NASDAQ - US
$ 45.65
-15.4 %
$ 5.81 B
Market Cap
16.42
P/E
Price Target
Average
18.29%
Revenue Forecast
Estimate
21.04%
EBIT
Estimate
15.25%
Net Income
Estimate
42.35%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Halozyme Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for HALO of $54 , with forecasts ranging from a low of $44 to a high of $65 .
HALO Lowest Price Target
Wall Street Target
44 USD
-3.61%
HALO Average Price Target
Wall Street Target
54 USD
18.29%
HALO Highest Price Target
Wall Street Target
65 USD
42.39%
REVENUE FORECAST
Revenue Forecast Chart HALO
EBIT FORECAST
EBIT Forecast Chart HALO
NET INCOME FORECAST
Net Income Chart HALO